Clinical Trials Browser

Phase 3 × Immunotherapy × 90 days × Clear all

NCT07613567 2026-05-29

A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer

Phase 3 Not yet recruiting

Locally Advanced Cervical Carcinoma

NCT07594340 2026-05-22

HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular